20+ years ago we did a lot of heart/drug research (mostly on septicemia but on regeneration as well). Too bad I'm no longer involved otherwise this avenue of heart research might have been up our alley.
Regardless, I agree with Comella becoming "toxic" with USRM and maybe that's why she decided it was best to step down. The PR mentioned it was "in good terms" (they didn't need to state anything really if that wasn't the case).
News 
Market Data 
Discover 
